Blocking Thromboxane-Prostanoid Receptor Signaling Attenuates Lipopolysaccharide- and Stearic Acid-Induced Inflammatory Response in Human PBMCs

被引:2
作者
Rajamanickam, Vinothkumar [1 ,2 ]
Desouza, Cyrus V. [1 ,2 ]
Castillo, Romilia T. [1 ,2 ]
Saraswathi, Viswanathan [1 ,2 ]
机构
[1] Univ Nebraska Med Ctr, Dept Internal Med, Div Diabet Endocrinol & Metab, Omaha, NE 68198 USA
[2] VA Nebraska Western Iowa Hlth Care Syst, Res Serv, Omaha, NE 68105 USA
关键词
thromboxane A2; inflammation; lipopolysaccharide; stearic acid; PBMC; ROCK; SYNTHASE INHIBITOR; DIABETES-MELLITUS; ANTAGONIST; ACTIVATION; OBESITY; MECHANISM; CELLS;
D O I
10.3390/cells13161320
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Inflammation is implicated in the etiology of obesity-related diseases. Thromboxane-prostanoid receptor (TPR) is known to play a role in mediating an inflammatory response in a variety of cells. Gut-derived lipopolysaccharide (LPS), a TLR4 agonist, is elevated in obesity. Moreover, free fatty acids (FFAs) are important mediators of obesity-related inflammation. However, the role and mechanisms by which TPR regulates the inflammatory response in human immune cells remain unclear. We sought to determine the link between TPR and obesity and the role/mechanisms by which TPR alters LPS- or stearic acid (SA)-induced inflammatory responses in PBMCs. Cells were pre-treated with agents blocking TPR signaling, followed by treatment with LPS or stearic acid (SA). Our findings showed that TPR mRNA levels are higher in PBMCs from individuals with obesity. Blockade of TPR as well as ROCK, which acts downstream of TPR, attenuated LPS- and/or SA-induced pro-inflammatory responses. On the other hand, TPR activation using its agonist enhanced the pro-inflammatory effects of LPS and/or SA. Of note, the TPR agonist by itself elicits an inflammatory response, which was attenuated by blocking TPR or ROCK. Our data suggest that TPR plays a key role in promoting an inflammatory response in human PBMCs, and this effect is mediated via TLR4 and/or ROCK signaling.
引用
收藏
页数:13
相关论文
共 37 条
  • [1] Mechanism linking diabetes mellitus and obesity
    Al-Goblan, Abdullah S.
    Al-Alfi, Mohammed A.
    Khan, Muhammad Z.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 587 - 591
  • [2] G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS
    ALTAVILLA, D
    SQUADRITO, F
    CANALE, P
    IOCULANO, M
    SQUADRITO, G
    CAMPO, GM
    SERRANO, M
    SARDELLA, A
    URNA, G
    SPIGNOLI, G
    CAPUTI, AP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (01) : 31 - 39
  • [3] Evaluation of a 12-Color Flow Cytometry Panel to Study Lymphocyte, Monocyte, and Dendritic Cell Subsets in Humans
    Autissier, Patrick
    Soulas, Caroline
    Burdo, Tricia H.
    Williams, Kenneth C.
    [J]. CYTOMETRY PART A, 2010, 77A (05) : 410 - 419
  • [4] Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation
    Capra, V.
    Back, M.
    Angiolillo, D. J.
    Cattaneo, M.
    Sakariassen, K. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (02) : 126 - 137
  • [5] BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase
    Cherdon, Celine
    Rolin, Stephanie
    Hanson, Julien
    Ooms, Annie
    de Leval, Laurence
    Drion, Pierre
    Michiels, Carine
    Pirotte, Bernard
    Masereel, Bernard
    Sakalihassan, Natzi
    Defraigne, Jean-Olivier
    Dogne, Jean-Michel
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2011, 94 (3-4) : 124 - 132
  • [6] Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection
    Collins, BJ
    Blum, MG
    Parker, RE
    Chang, AC
    Blair, KSA
    Zorn, GL III
    Christman, BW
    Pierson, RN III
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2001, 90 (06) : 2257 - 2268
  • [7] Therapeutic potential of thromboxane inhibitors in asthma
    Dogné, JM
    de Leval, X
    Benoit, P
    Rolin, S
    Pirotte, B
    Masereel, B
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (02) : 275 - 281
  • [8] Obesity and inflammation: the linking mechanism and the complications
    Ellulu, Mohammed S.
    Patimah, Ismail
    Khaza'ai, Huzwah
    Rahmat, Asmah
    Abed, Yehia
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (04) : 851 - 863
  • [9] Thromboxane Receptor Signaling Is Required for Fibronectin-induced Matrix Metalloproteinase 9 Production by Human and Murine Macrophages and Is Attenuated by the Arhgef1 Molecule
    Hartney, John M.
    Gustafson, Claire E.
    Bowler, Russell P.
    Pelanda, Roberta
    Torres, Raul M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (52) : 44521 - 44531
  • [10] Liver Kinase B1 Is Required for Thromboxane Receptor-Dependent Nuclear Factor-κB Activation and Inflammatory Responses
    He, Jinlong
    Zhou, Yanhong
    Xing, Junjie
    Wang, Qilong
    Zhu, Huaiping
    Zhu, Yi
    Zou, Ming-Hui
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (06) : 1297 - +